Loading
Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille
Marseille's university hospital, where Jean-Jacques Grob's dermatology department, Olivier Chinot's neuro-oncology unit and Florence Duffaud's sarcoma group have each led international trials.
Also called: AP-HMLa TimoneCHU de MarseilleAix-Marseille University Hospital
Overview
Hôpital de la Timone is the largest hospital of Assistance Publique-Hôpitaux de Marseille and the main teaching hospital of Aix-Marseille University. Its Department of Dermatology and Skin Cancer under Jean-Jacques Grob led KEYNOTE-629 in cutaneous squamous-cell carcinoma and contributed to the major melanoma trials; the neuro-oncology unit under Olivier Chinot led AVAglio in glioblastoma; and the medical oncology department under Florence Duffaud coordinated the French Sarcoma Group's REGOBONE trial in bone sarcomas. The Institut Paoli-Calmettes, the region's dedicated cancer centre, is a separate institution across the city.
Location
Marseille, FR
Type
hospital · Aix-Marseille Université
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#438 · 10 points (0 Newsweek + 0 NCI + 10 from 5 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Assistance Publique Hôpitaux de Marseille, including child institutions. 509 works · 5,706 citations · 66% open access · 17% clinical trials · 2% reviews.
Oncology works per year
1002022
1012023
1152024
1232025
702026
Most works
- Jean‐Jacques Grob49 works
- Laurent Greillier48 works
- Paolo A. Ascierto35 works
- Stéphane Dalle33 works
- Caroline Gaudy‐Marqueste29 works
- Georgina Venetia Long29 works
- Célèste Lebbé24 works
- Lionel Falchero24 works
- Michele Del Vecchio22 works
- Caroline Dutriaux22 works
Most cited
Programmes
3- Dermato-oncology
- Neuro-oncology
- Sarcoma (French Sarcoma Group)
People
3Florence Duffaud
Medical oncologist, Hôpital de la Timone, Aix-Marseille University
Bone sarcomaGastrointestinal stromal tumourKinase inhibitors in sarcoma
Marseille oncologist who led REGOBONE, the trial that showed regorafenib delays progression in metastatic osteosarcoma and other bone sarcomas.
Jean-Jacques Grob
Professor of Dermatology, Aix-Marseille University, Hôpital de la Timone
MelanomaCutaneous squamous-cell carcinomaAdjuvant immunotherapy
Marseille dermatologist who led KEYNOTE-629, which established pembrolizumab for advanced cutaneous squamous-cell carcinoma, and who has been a senior investigator on many European melanoma trials.
Olivier L. Chinot
Neuro-oncologist, Aix-Marseille University and Hôpital de la Timone
GlioblastomaAnti-angiogenic therapyNeuro-oncology trials
Marseille neuro-oncologist who was lead author of AVAglio, the trial that showed adding bevacizumab to standard glioblastoma treatment delays progression but does not lengthen life.
Connected
8Similar pages
- Key paperKEYNOTE-629: pembrolizumab monotherapy for recurrent or metastatic cutaneous squamous cell carcinoma
Shares Jean-Jacques Grob, Advanced cutaneous squamous cell carcinoma.
- TrialAVAglio
Shares Olivier L. Chinot, Glioma & glioblastoma.
- TrialREGOBONE
Shares Florence Duffaud, Osteosarcoma.
- TreatmentCobolimab
Shares Osteosarcoma, Glioma & glioblastoma, Melanoma.
- TargetERCC2
Shares Osteosarcoma, Melanoma.
- TrialA Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
Shares Osteosarcoma, Melanoma.
- CancerChondrosarcoma
Shares Florence Duffaud, Osteosarcoma.
- TreatmentVusolimogene oderparepvec
Shares Advanced cutaneous squamous cell carcinoma, Melanoma.
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
ap-hm.fr · 1
A source that has moved or gone is reported by the weekly link check. /audit/
ProvenanceLast edited 2026-09-18 · Jude Gomila · Fill institutions for 78 trial investigators and add 41 i… · diff · file
Sourced, not expert-reviewed